Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Jacqueline Bachofner(University Hospital Zurich), The Swiss Hepatitis C Cohort Study, Benedetta Terziroli Beretta‐Piccoli(Ente Ospedaliero Cantonale), Beat Müllhaupt(University Hospital of Zurich), Adriana Baserga(Epatocentro Ticino), Anja Moncsek(University Hospital of Zurich), Patrizia Künzler‐Heule(University of St.Gallen), Jan Fehr(University Hospital of Zurich), David Semela(Kantonsspital St. Gallen), Arne Kröger(University Hospital Zurich), Irina Bergamin(University of St.Gallen), Dominique L. Braun(University of Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Burkhardt Seifert(Omega Consult (Slovenia)), Piero V. Valli(University Hospital of Zurich), Lorenzo Magenta(Epatocentro Ticino)
Cited by 16
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k